CR20200472A - Novel peptides and combination of peptides for use in immunotherapy against various tumors - Google Patents

Novel peptides and combination of peptides for use in immunotherapy against various tumors

Info

Publication number
CR20200472A
CR20200472A CR20200472A CR20200472A CR20200472A CR 20200472 A CR20200472 A CR 20200472A CR 20200472 A CR20200472 A CR 20200472A CR 20200472 A CR20200472 A CR 20200472A CR 20200472 A CR20200472 A CR 20200472A
Authority
CR
Costa Rica
Prior art keywords
peptides
combination
present
tumor
relates
Prior art date
Application number
CR20200472A
Other languages
Spanish (es)
Inventor
Jens Fritsche
Harpreet Singh
Oliver Schoor
Toni Weinschenk
Lea Stevermann
Andrea Mahr
Original Assignee
Immatics Biotechnologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immatics Biotechnologies Gmbh filed Critical Immatics Biotechnologies Gmbh
Priority claimed from PCT/EP2016/056557 external-priority patent/WO2016156202A1/en
Publication of CR20200472A publication Critical patent/CR20200472A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

<p>The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor- associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.</p>
CR20200472A 2016-03-24 2016-03-24 Novel peptides and combination of peptides for use in immunotherapy against various tumors CR20200472A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16056557 2016-03-24
PCT/EP2016/056557 WO2016156202A1 (en) 2015-03-27 2016-03-24 Novel peptides and combination of peptides for use in immunotherapy against various tumors

Publications (1)

Publication Number Publication Date
CR20200472A true CR20200472A (en) 2021-01-26

Family

ID=65236531

Family Applications (6)

Application Number Title Priority Date Filing Date
CR20200477A CR20200477A (en) 2016-03-24 2016-03-24 Novel peptides and combination of peptides for use in immunotherapy against various tumors
CR20200474A CR20200474A (en) 2016-03-24 2016-03-24 Novel peptides and combination of peptides for use in immunotherapy against various tumors
CR20200475A CR20200475A (en) 2016-03-24 2016-03-24 Novel peptides and combination of peptides for use in immunotherapy against various tumors
CR20200472A CR20200472A (en) 2016-03-24 2016-03-24 Novel peptides and combination of peptides for use in immunotherapy against various tumors
CR20200473A CR20200473A (en) 2016-03-24 2016-03-24 Novel peptides and combination of peptides for use in immunotherapy against various tumors
CR20170522A CR20170522A (en) 2016-03-24 2016-03-24 PEPTIDES AND COMBINATION OF NOVELED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

Family Applications Before (3)

Application Number Title Priority Date Filing Date
CR20200477A CR20200477A (en) 2016-03-24 2016-03-24 Novel peptides and combination of peptides for use in immunotherapy against various tumors
CR20200474A CR20200474A (en) 2016-03-24 2016-03-24 Novel peptides and combination of peptides for use in immunotherapy against various tumors
CR20200475A CR20200475A (en) 2016-03-24 2016-03-24 Novel peptides and combination of peptides for use in immunotherapy against various tumors

Family Applications After (2)

Application Number Title Priority Date Filing Date
CR20200473A CR20200473A (en) 2016-03-24 2016-03-24 Novel peptides and combination of peptides for use in immunotherapy against various tumors
CR20170522A CR20170522A (en) 2016-03-24 2016-03-24 PEPTIDES AND COMBINATION OF NOVELED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

Country Status (1)

Country Link
CR (6) CR20200477A (en)

Also Published As

Publication number Publication date
CR20170522A (en) 2018-12-21
CR20200477A (en) 2021-01-26
CR20200474A (en) 2021-01-26
CR20200475A (en) 2021-01-26
CR20200473A (en) 2021-01-25

Similar Documents

Publication Publication Date Title
PH12018500551A1 (en) Novel peptides and combination of peptides for use in immunotherapy against various cancers
CR20200560A (en) Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers
CR20200471A (en) Novel peptides and combination of peptides for use in immunotherapy against various tumors
CR20200595A (en) Novel peptides and combination of peptides for use in immunotherapy against cll and other cancers
CR20200431A (en) Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
CR20200555A (en) Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
CR20210036A (en) Uterine cancer treatments
CR20210130A (en) Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
PH12019502308A1 (en) Peptides and combination thereof for use in the immunotherapy against cancers
CR20200638A (en) Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
MX2018010875A (en) Novel peptides and combination of peptides for use in immunotherapy against various tumors.
CR20200607A (en) Immunotherapy against melanoma and other cancers
MY196837A (en) Novel peptides and combination of peptides for use in immunotherapy against various cancers
PH12018502108A1 (en) Novel peptides and combination of peptides for use in immunotherapy against aml and other cancers
PH12018501639A1 (en) Novel peptides and combination of peptides for use in immunotherapy against nhl and other cancers
CR20200477A (en) Novel peptides and combination of peptides for use in immunotherapy against various tumors